A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-880 in Subjects Who Have Type 1 Diabetes Mellitus With Impaired Hypoglycemic Awareness and Severe Hypoglycemia
2025-05-08
عنوان الدراسة
A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-880 in Subjects Who Have Type 1 Diabetes Mellitus With Impaired Hypoglycemic Awareness and Severe Hypoglycemia
داعم الدراسة
Vertex / CTI
دواء الدراسة
VX 880
رقم بروتوكول الدراسة
VX20-880-101
حالة الدراسة
Ongoing
موقع الدراسة
King Abdulaziz Hospital NG (Riyadh)
مرحلة الدراسة
3
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。